Monday, September 25, 2017 11:41:45 AM
Have to raise capital in order to take care of filing obligations to get current somehow, in their PR it stated they didn't have the means to get current, this solves that problem.
Convertable at .05, not .0005, so they can't be used to dilute this to nothing like most OTCs tend to do.
Convertable at .05, not .0005, so they can't be used to dilute this to nothing like most OTCs tend to do.
Recent ALRTF News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/20/2026 05:17:03 PM
- ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA • PR Newswire (US) • 05/19/2026 12:28:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:06:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 04:57:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2026 06:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:49:39 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:38:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/07/2025 09:10:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/26/2025 05:31:37 PM
